Nyxoah

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat obstructive sleep apnea (OSA). Its lead solution platform is the Genio system, described as an FDA approved and CE-Mark validated, user-centered, bilateral neurostimulation therapy for moderate to severe OSA, intended as an alternative for people who cannot tolerate, have failed, or refused CPAP therapy. The company is based in Mont-Saint-Guibert, Belgium.

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat obstructive sleep apnea (OSA). Its lead solution platform is the Genio system, described as an FDA approved and CE-Mark validated, user-centered, bilateral neurostimulation therapy for moderate to severe OSA. The company is based in Mont-Saint-Guibert, Belgium.

A medical technology company focused on innovative solutions to treat obstructive sleep apnea, with the Genio system as its lead solution platform.

• Genio system

  A patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA; described as an FDA approved and CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe OSA.

• 2021.11.08

  Reported2021.11.08

  Nyxoah announces Loïc Moreau as incoming CFO[4]Nyxoah 宣布 Loïc Moreau 将出任新任首席财务官finanznachrichten.de

  Nyxoah announced that Loïc Moreau will join the company as CFO on January 1, 2022, replacing Fabian Suarez, who is to leave at the end of 2021.

• 2021.07.08

  Reported2021.07.08

  Nyxoah underwriters exercise option for additional IPO shares[5]Nyxoah 承销商全额行使额外 IPO 配售股份购买权finance.yahoo.com

  Nyxoah announced that the underwriters had exercised in full their option to purchase up to 425,250 additional shares at US$30 per share. Closing of the option exercise was expected on July 9, subject to customary conditions.

• 2020.09.09

  Reported2020.09.09

  Nyxoah announces initial public offering on Euronext Brussels[6]Nyxoah宣布在布鲁塞尔泛欧交易所首次公开募股finance.yahoo.com

  Nyxoah announced the terms of an initial public offering of new shares, with admission to trading of all its shares on the regulated market of Euronext Brussels.

• 2020.08.27

  Reported2020.08.27

  Nyxoah announces intention to launch an IPO[7]Nyxoah宣布拟进行首次公开募股finanznachrichten.de

  Nyxoah announced its intention to raise funds through an initial public offering and seek admission of all its shares to the regulated market of Euronext Brussels. The offering was presented as subject to approval of the prospectus.

• 2020.02.12

  Reported2020.02.12

  Nyxoah announces €25 million private financing round[8]Nyxoah宣布完成2500万欧元私人融资finanznachrichten.de

  Nyxoah announced a €25 million private financing round, with ResMed joining as a new shareholder. Completion was subject to customary closing conditions and expected later that month.

Read more

1. 1| Nyxoahnyxoah.com
2. 2About Nyxoah | Nyxoahnyxoah.com
3. 3Nyxoah (Belgium)wikidata.org
4. 4Nyxoah 宣布 Loïc Moreau 将出任新任首席财务官finanznachrichten.de
5. 5Nyxoah 承销商全额行使额外 IPO 配售股份购买权finance.yahoo.com
6. 6Nyxoah宣布在布鲁塞尔泛欧交易所首次公开募股finance.yahoo.com
7. 7Nyxoah宣布拟进行首次公开募股finanznachrichten.de
8. 8Nyxoah宣布完成2500万欧元私人融资finanznachrichten.de